ACI
SCLN

AMP Capital Investors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

AMP Capital Investors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-144,600
Closed -$741K – 1357
2013
Q2 		$741K Buy
+144,600
New +$688K 0.01% 985

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AMP Capital Investors's SCLN Position: Q3 2013 in Review

AMP Capital Investors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2013, closing a stake of 144,600 shares — an estimated $741K sold.

AMP Capital Investors first reported a position in SCLN in Q2 2013 and held it in 1 quarter. The position peaked at $741K in Q2 2013. 102 funds tracked by Wall St. Rank hold SCLN as of Q3 2013.

  • AMP Capital Investors reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • AMP Capital Investors sold 144,600 Sciclone Pharmaceuticals Inc shares in Q3 2013, an estimated $741K.
  • AMP Capital Investors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • AMP Capital Investors's Sciclone Pharmaceuticals Inc position peaked at $741K in Q2 2013.
  • 102 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2013.

Based on AMP Capital Investors's 13F filing for Q3 2013, filed 14 Nov 2013.